Literature DB >> 679131

Bone marrow acid phosphatase concentrations in individuals with prostatic carcinoma or other disorders.

C Little, A M Shojania, P T Green, B H Weinerman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 679131      PMCID： PMC1818165     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN： 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  5 in total

1.  Bone marrow acid phosphatase in staging prostatic carcinoma.

Authors:  J E Pontes; S W Alcorn; A J Thomas; J M Pierce
Journal:  J Urol       Date:  1975-09       Impact factor: 7.450

2.  Usefulness of bone marrow serum acid phosphatase in staging carcinoma of the prostate.

Authors:  R D Reynolds; B R Greenberg; N D Martin; R N Lucas; C N Gaffney; L Hawn
Journal:  Cancer       Date:  1973-07       Impact factor: 6.860

3.  Sodium thymolphthalein monophosphate: a new acid phosphatase substrate with greater specificity for the prostatic enzyme in serum.

Authors:  A V Roy; M E Brower; J E Hayden
Journal:  Clin Chem       Date:  1971-11       Impact factor: 8.327

4.  Bone marrow acid phosphatase: prognostic value in patients undergoing radical prostatectomy.

Authors:  R J Veenema; E O Gursel; N Romas; M Wechsler; J K Lattimer
Journal:  J Urol       Date:  1977-01       Impact factor: 7.450

5.  New diagnostic use of bone marrow acid and alkaline phosphatase.

Authors:  G Yarrison; B F Mertens; J C Mathies
Journal:  Am J Clin Pathol       Date:  1976-10       Impact factor: 2.493
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.